One of the most detailed maps to date of meningioma—the most common brain tumor in adults—reveals how the tumor's surrounding ...

For patients diagnosed with IDH-mutant glioma, an incurable brain tumor that often affects adults in their 30s and 40s, ...

Immune checkpoint therapy, a type of cancer immunotherapy that helps the immune system recognize and attack tumors, has ...

The inflammatory tumor microenvironment (TME) is a complex network of cancer, immune, and stromal cells interacting through cytokines and growth factors to drive tumor growth, angiogenesis, and immune ...

A new research paper was published in Volume 17 of Oncotarget on May 20, 2026, titled “Microenvironmental CTHRC1 has a ...

Pancreatic cancer cells are known for being hard to treat, partly because they change the environment around them to block drugs and immune cells. Scientists discovered that these tumors use a ...

In a study published in Science, researchers from The University of Texas MD Anderson Cancer Center have developed a spatial atlas of specialized immune structures, called tertiary lymphoid structures ...

Doxorubicin (DOX), also known as adriamycin (ADR), is a potent chemotherapeutic drug applied in the clinics for the treatment of a wide range of human cancers, including Hodgkin's lymphoma, leukemia, ...

A small clinical trial led by Dana-Farber Cancer Institute researchers has put a Salk Institute idea to the test in patients: ...

Safety, efficacy, and outcomes of 90-yttrium radioembolization in combination with immune checkpoint inhibitors as a definitive first-line treatment approach in non-surgical hepatocellular carcinoma.